Looking Into Black Diamond Therapeutic's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Black Diamond Therapeutics (NYSE:BDTX) has seen a 6.83% decrease in its short percent of float, now at 13.23%. This is higher than its peers' average of 11.18%. It would take traders 13.4 days to cover their short positions.
August 22, 2024 | 1:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Black Diamond Therapeutics has experienced a decrease in short interest, now at 13.23% of float, which is higher than its peers' average. This could indicate a shift in market sentiment.
The decrease in short interest suggests a potential shift towards a more bullish sentiment among investors. With short interest still above peers' average, it indicates that while bearish sentiment is decreasing, caution remains. The time to cover shorts is relatively long, which could lead to a short squeeze if positive news emerges.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100